Abstract: Background: Contemporary neurobiology, periodontal medicine, and immunology are now focusing on the relationship between chronic periodontitis and systemic diseases, which also include Alzheimer's disease (AD). However a causative relationship between dementia and periodontitis has yet to be confirmed.
INTRODUCTION
A possible link between cognitive impairment and dementia, and systemic inflammatory diseases like periodontitis are postulated and investigated from over decade. Dementias are a set of multi-etiologic brain disorders characterized by the acquired behavioral and cognitive deficits. It primarily affects the elderly, but unfortunately neurodegenerative changes can commence at any age. Dementia has many origins, among which Alzheimer's disease (AD) is the major cause. AD is multifactorial disease, concerned as systemic diseases, because of affect both central nervous system (CNS) and systemic processes [1] . AD is characterized by *Address correspondence to this author at the Laboratory of Virology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wroclaw, Poland; Tel: +4871-3709924; Fax: +48-71-337 2171; E-mail: mars@iitd.pan.wroc.pl early neuronal loss and associated with multiple risk factors. It is the most common type of dementia (50 to 75 % of cases) in elderly above 60 years old and it represents one of the main socio-health problems in almost every country in the world [2] [3] [4] . Among the most important AD risk factors, age, sex, and genetic abnormalities are non-modifiable. There is no effective approaches that can slow, stop or reverse the AD process, therefore the identification of altered risk factors is important to prevent AD. The increasing studies suggest that gingivitis and periodontitis may be the modifiable risk factors of AD [5] . In elderly, periodontitis is common because of reduced ability to take care of oral hygiene, which can stimulate recurrent chronic oral infection [6, 7] . The correlation between periodontitis and the prevalence of cardiovascular diseases and diabetes has been shown. [8, 9] , but the relationship between periodontitis and dementia is still needed to clarify.
One of the most important features of AD neuropathology is neuroinflammation, an inflammatory process pending in the brain, which can be enhanced by systemic inflammation. β-amyloid (Aβ) plagues and tau neurofibrillary tangles are associated with initiation of the immune response in the brain tissue [10, 11] . The key mediators of activation and maintaining the inflammatory processes, are cytokines produced by glia cells and leukocytes infiltrating the brain from periphery. Inflammation and pro-inflammatory mediators, blood vessel damage, and oxidative stress have been found to be capable of inducing neurodegeneration, resulting in neuronal loss and brain injury [10, [12] [13] [14] . A number of reports indicating elevated levels of pro-inflammatory cytokines, like TNF-α, IL-1α/β, IL-6 or IL-8 in the brains, blood and cerebrospinal fluid (CSF) of AD patients [15] [16] [17] . In the brain, inflammation may be caused by a local central nervous system insult and/or by peripheral infections. Currently, it is postulated that infections elsewhere in the body might aggravate inflammatory processes in the brain. Among the microorganisms suspected in AD, human herpesvirus type 1 (HHV-1), but also Candida species and several non-oral and oral bacteria are intensively investigated [18] [19] [20] . Periodontitis is a peripheral chronic infection caused by certain oral pathogens, that elicits a significant systemic inflammatory response [21] . The bacterial antigens from the biofilm that cover the surface of the oral mucosa affect the processes responsible for the local tolerance and immune and systemic response. Thus, periodontal disease may be an important source of systemic inflammatory molecules [22, 23] . TNF-α, IL-1β, IL-6, IL-8 and IL-10 are associated with the inflammatory process induced by LPS of periodontal microorganisms, present in the oral cavity or infiltrating into the blood [24, 25] . Moreover, as it is suggested, LPS can access the AD brain during life and elevated antibodies of periodontal pathogens have been found in AD patients as well as in chronic periodontitis patients [19, 24, 26] . It is postulated that the pro-inflammatory mediators have an effect on local inflammatory processes, but also support systemic inflammation in distant organs. Moreover, it is known that systemic inflammation and chronic exposure to pro-inflammatory mediators may exacerbate the neurodegenerative environment by stimulation of the production of amyloid-β (Aβ) and tau protein [17, 27, 28] . These findings became the basis of the hypothesis that clinical periodontitis is associated with incidence and progression of AD [27] .
Recently it was reported that there is an association between oral health status and cognitive decline in AD [29] , and there are suggestions that chronic oral infection promotes inflammation, which can add to the inflammatory pool by contributing several pro-inflammatory mediators, and lead to confusion and dementia [19, 30] . However there is still not enough convincing data about the relationship between periodontal and cognitive impairment and systemic inflammation. The study objective is to determine whether periodontal health status and cognitive abilities are correlated with the relative changes in systemic measures of pro-and anti-inflammatory cytokines as a reflection of systemic inflammation. We hypothesized that poor periodontal health status may be associated with cognitive impairment and dementia via the exacerbation of systemic inflammation.
MATERIALS AND METHODS

Participants
The 
Periodontal Examination
The periodontal examination of all the subjects was manually performed with a mirror and University of North Carolina (UNC)-15 periodontal probe (Hu Friedy, Chicago, IL, USA) by a single researcher (A.S-J). Number of teeth and measures of probing depth in mm (PD), clinical attachment level in mm (CAL), and gingival inflammation measured as bleeding on probing (yes/no) (BoP) and oral hygiene status by approximal plaque index (API) were recorded at 6 sites (at the disto-, mid-, and mesio-buccal as well as the lingual positions) on all teeth except the third molars. The clinical diagnosis of moderate and severe periodontitis was based on Page & Eke classification [31] . All the participants did not receive treatment for periodontal disease in the past 6 months.
Psychiatric Examination
The baseline examination included psychiatric and neurological examinations, as well as laboratory tests, electroencephalographic examinations (EEG) and computer tomography (CT) or MRI structural studies. Mini-mental State Examination (MMSE) was used for the screening of dementia. All patients enrolled in the study met DSM-V and NINCDA-ADRDA criteria for probable AD dementia. The exclusion criteria for all evaluated subjects were severe head injury, headache, street drug or oral steroid use, current alcohol abuse or dependence, loss of 25% of the weight in the past year. Subjects with cerebral vascular damage or vascular risk factors were also excluded from the study. The additional exclusion criterion was any history of major psychiatric or central nervous system illness. Patients were excluded if they did not agree to respond to the test questions and/or if they had life-threatening diseases other than AD.
Standard Protocol Approval
These studies have been approved by the Bioethics Committee of the Wroclaw Medical University (approval number 350/2013) with written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki.
Isolation of Peripheral Blood Leukocytes (PBL)
PBL from participants included into the study were isolated as previously described [32] .
PBL Culture and Stimulation
Freshly isolated PBL (ex vivo) were divided into two parts. One part of the PBL (2x10 6 cells mL -1 ) was suspended in PRMI medium with 2% of fetal bovine serum (FBS) and incubated 24 h at 37 ºC/ 5% CO 2 (unstimulated leukocytes). The second part of the PBL (2x10 6 cells mL -1 ) was suspended in PRMI medium with 2% FBS and stimulated with 1 µg mL -1 of LPS (Sigma, Poland). Next cells were incubated 24 h at 37 ºC/ 5% CO 2 . Samples of medium above the PBL were collected after 24h of incubation and stored at -80 ºC for cytokines determination.
Cytokine Assay
Cytokine levels were determined in the supernatants using ELISA kits (Biomedical Laboratories, USA; BD Biosciences, USA) for human IL-1β, IL-6, IL-10, TNF-α according to the producers' instructions. The optical density was measured at 450 nm using a Multiskan RC spectrophotometric reader (Thermo Labsystems, USA). Cytokine concentrations were expressed in pg/ml. 
Statistical Methods
Let
. Relationship between cytokine levels, j C , and score results of both MMSE and BoP test was summarized, at first, by conditional averages given the test's result, i.e. conditional average level of th j − cytokine is ( )
, respectively, where
P are limits of intervals in Tables 2 and 3 . To show these relationships more understandable ( Fig. 1 ) respective curves were fitted to the obtained points. Table 1 contains characteristics of the parameters investigated in this study. It was shown that the median of age is 70 = Med years, 75% of cases were older then 61 1 = Q years, 25% of cases were older than 77 3 = Q years. Similarly, the average level of TNF produced by unstimulated PBL was 62 = Med pg/ml, in 75% of cases TNF level was higher than 22 1 = Q pg/ml, and 25 % of cases were higher than 175 3 = Q pg/ml. The average level of TNF produced by LPS-induced PBL was 962 = Med pg/ml, in 75% of cases TNF level was higher than 572 1 = Q pg/ml, and 25 % of cases were higher than 1618 3 = Q pg/ml. Characteristics of the remaining parameters similarly as above. All participants were brought under thorough periodontal and psychiatric examination, and for our studies BoP and MMSE results were chosen. BoP is an indicator of gingival inflammation and is effective in monitoring of periodontal disease (33) . It does not allow for diversity between periodontitis and gingivitis, but in our study participants with diagnosed periodontitis (according to CAL and PD, see Materials and methods) and not only gingivitis were included. MMSE were used as a standard test for screening of cognitive impairment and dementia.
RESULTS
Summary Characteristics of the Parameters Analyzed in the Study
Cytokine Profile and Clinical Parameters
Firstly, we have investigated if the level of the cytokines IL-1β, IL-6, IL-10 and TNF-α, as a marker of systemic inflammation, is associated with periodontal health status and cognitive impairment. For this purpose PBL from blood samples from 128 participants were isolated. After 24-hour incubation, supernatants above PBL for cytokine determination were collected.
In Table 2 we showed the averages of cytokine levels among participants divided into five groups Average concentrations are presented in relative scales, with minimal concentrations as a baselines (minimal concentrations taken as 1). Data presented in Table 1 and Table 2 . The conditional averages of cytokines levels (points). Fitted curves were included (lines).
kines and BoP test show similar results as above. In Table 3 we showed the averages of cytokines levels among participants divided into four groups, Summarizing, the average level of every investigated cytokine, produced by unstimulated PBL ex vivo, raised with the increase in BoP test, what is connected with worse periodontal health status, and with fall in MMSE test, what is correlated with cognitive decline and dementia. Fig. (1) presents the relative concentrations of investigated cytokines, presented in the Table 2 and Table 3 , points with fitted curves (lines). Obtained results were good starting points for indepth analysis of this research problem, when we take into consideration all cytokines together, with an interaction between them, and examine the relationship between inflammatory state and cognitive and periodontal impairment.
Relationship between Cognitive and Periodontal Impairment and Systemic Inflammation
Next, we have attempted to explain if periodontal and cognitive impairment contribute to the increase in systemic inflammation, and, if the presence of these two disorders is connected with higher inflammatory state compared to the presence of only one of these conditions. For this purpose MMSE and BoP test results were treated as one specific condition, that we called Cognitive and periodontal impairment state. Both scores were included into the single function, to better describe the clinical state of every investigated participant. This state was next compared to the Inflammatory state, measured by the levels of cytokines IL-1β, IL-6, IL-10 and TNF-α, produced by unstimulated and LPSstimulated PBL. , it simplifies that if the level of the rest of cytokines is ignored, the higher level of the IL-1β always will be connected with higher level of the Inflammatory state, etc. In the 
). The correlation between Cognitive and periodontal impairment state (U), measured as a function of MMSE and BoP (see Statistical methods) and Inflammatory state (V), as a function of the levels of cytokines produced by LPS-stimulated PBL it is presented on Fig. (3) .
Therefore, worse periodontal health status (higher BoP score) as well as cognitive decline (lower result in MMSE test) (via negative value of the M β coefficient) are connected with the higher level of the Cognitive and periodontal impairment state (via positive P β ) and higher Inflammatory state, as a reflection of systemic inflammation measured by the levels of cytokines produced by LPS-stimulated PBL. According to the obtained results we have seen that unstimulated as well as LPS-stimulated PBL ex vivo respond similarly by producing the elevated levels of systemic inflammatory markers IL-1β, IL-6, IL-10 and TNF-α. Moreover, all the cytokines are positively correlated with the inflammatory state. Thus, it confirms that poor periodontal health status and cognitive decline aggravate the inflammatory response. Tables 4 and 5 as well as on the (Figs. 2 and 3 (Table 4) . This correlation is reflected by the red curve on Fig. (4) . Based on the results presented on the (Fig. 4) 
Based on the results presented in
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DISCUSSION
Still increasing number of studies suggest the relationship between periodontitis and cognitive decline and AD [3, 27, 29, 30, 34] but the link is elusive and the exact mechanism is still unclear. Periodontitis can lead to the AD progression, and two probable mechanisms are proposed: periodontitis preceding systemic inflammation/infection and bacterial and viral influence [35] . The chronic inflammatory response that occurs in AD is a complex process that involves innate and adaptive cells and their produced inflammatory mediators (TNFα, IL-1, IL-6, IL-7, IL-10, IL-15 and IL-18) [36] . Cytokines IL-1, IL-6, IL-10 and TNF-α are involved in the pathogenesis of periodontitis and are a good biomarkers of nonsurgical treatment of chronic periodontitis [37] [38] [39] .
While the influence of inflammatory processes in the pathogenesis of periodontitis and AD is reported, this study addressed whether there is a relationship between pro-and anti-inflammatory cytokine profile, that plays an important role in the immune response in periodontal disease and AD, and the results of the BoP test and MMSE test, as a reflection of periodontal health status and cognitive abilities. It has been shown that the level of pro-inflammatory cytokines IL-1, IL-6 and TNF-α but also anti-inflammatory IL-10, produced by PBL ex vivo, increases with worsened periodontal status (increase of BoP score) and cognitive decline (fall of MMSE score). These results confirmed early observations that the systemic inflammatory markers are elevated in diagnosed cognitive impairment and AD patients with periodontitis. For example, it has been shown that in AD patients with periodontitis the antibodies of common periodontal bacteria and plasma levels of TNF-α are increased [40] . Three folds higher level of TNF-α in serum of AD patients with chronic periodontitis was also presented [41] . Ide et al. investigated an association between periodontitis and cognitive decline in AD by the measurement of serum level of pro-and antiinflammatory markers. They show a relative increase in the levels of CRP and TNF-α and decrease in IL-10 over a six month follow up period in AD participants with periodontitis, but the results are not informative because of the small numbers of participants and because of the large data scatter. Thus, the future investigations that could confirm these results are needed.
It was presented earlier that PBMCs from patients with chronic periodontitis have suppressed anti-inflammatory cytokine production (IL-10) [42] and that the IL-10 production was restored after blocking the pro-inflammatory cytokine release by peripheral blood mononuclear cells (PBMC) from chronic periodontitis patients in response to P. gingivalis LPS. We showed an increase in IL-10 production by PBL, therefore it seems that the cytokine profile, as well as the inflammatory state associated with the presence of both periodontitis and cognitive impairment, change the leukocyte response, which replay with the increased production of both pro and anti-inflammatory cytokines. Moreover IL-10 is known as a down-regulator of IL-1 production, so higher level of pro-inflammatory cytokine (IL-1β, IL-6 and TNF-α) may lead to an increase in IL-10 release. The elevated levels of both pro-and anti-inflammatory cytokines were also observed in patients with periodontitis and other systemic diseases, like rheumatoid arthritis or inflammatory bowel disease [43, 44] . To test the hypothesis that the coexisting of poor periodontal status and cognitive impairment may exacerbate the systemic inflammation, we have measured the level of pro-(IL-1β, IL-6 and TNF-α) and anti-inflammatory IL-10 systemic markers produced by unstimulated and LPS-stimulated PBL. All participants were brought under thorough periodontal and psychiatric examination, but for our analysis BoP and MMSE tests results were chosen. The reason was that the BoP is effective in the diagnosis and monitoring of active periodontal diseases but also is a reliable indicator of gingival inflammation [33] . However, measurement of the PoB does not allow for diversity between periodontitis and gingivitis, but we confirm that in our study, participants diagnosed with periodontitis and not only gingivitis were included. MMSE is a standard test used for the evaluation of cognitive decline (screening of cognitive impairment and dementia). There are some limitations to the current research that may affect the results. One could not expect that there will be a simple correlation between the level of particular cytokines and the number of points in the MMSE test. Inflammation is a complex process and there is no simple relationship between inflammation and the level of individual cytokine level and the relationship between cytokine level and BoP or MMSE results. Therefore, in this study we have used such-and-such methodology, where the MMSE and BoP test results are combined into the one value (U) with a particular function, whose the result determines the severity of specific condition, that we collectively called Cognitive and periodontal impairment state. Similarly, the levels of cytokines were combined into the one function (V) whose value (the result of adding cytokine concentrations and multiplied by their coefficients β Μ ) determines the level of Inflammatory state, as a reflection of systemic inflammation.
It was suggested previously that the higher prevalence of both conditions (periodontitis and dementia) in elderly could imply that their association might be coincidental [34] . We have shown the evidence that the higher BoP result (worsened bleeding), which means periodontal health problems, the higher U-function value (Cognitive and periodontal impairment state), because β P for the BoP is positive and significantly higher than zero. Likewise, we presented that the less points in MMSE test, which indicates on the cognitive impairment and dementia, means, again, the higher Ufunction value because of the negative β Μ for the MMSE. It means that the cognitive impairment and dementia (fall in MMSE test) and periodontal disease (high BoP), when coexist together, lead to the higher systemic inflammation compared to the prevalence of only one of these conditions. Thus, we confirmed early proposed mechanism, where inflammatory mediators of periodontitis may contribute to, exacerbate, and share risk factors with dementia [45] . These observations are significant to better understand the mechanisms involved in the pathogenesis of neuroinflammatory diseases, like AD. The increase of systemic inflammation leads to the rise of pro-inflammatory cytokines that may enter into the brain through the more permeable blood brain barrier (BBB) and stimulate the glial cells to synthesize additional pro-inflammatory cytokines and evoke neuroinflammation. Periodontitis is a significant source of systemic inflammatory molecules, that causes or promotes other chronic systemic inflammatory diseases, and an association between periodontal disease and brain Aβ load in humans was shown [23, 46] .
Therefore it is reasonable to consider periodontal health problems as a modifiable risk factor of cognitive impairment and dementia, and early treatment of periodontitis may limit severity and progression of cognitive lesions. Future research using more accurate, especially psychiatric, examinations, and designation of other systemic inflammatory markers are most welcome and warranted to support this investigation.
CONCLUSION
The inflammatory processes change along with the disease process and the impact of numerous biomarkers, like cytokines still produced by immune cells, may be different at different points in the disease. The prevalence of the various neuropsychiatric symptoms and neurodegenerative changes alter over the course of the disease and it is very likely that the presence of additional source of pro-inflammatory mediators, like periodontal disease, might not initiate AD but exacerbate the systemic inflammation and thus deepen the neurodegenerative lesions.
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